Novabridge BiosciencesNBP
13F holders, Q2 2025 (June 30)32holders +3
10new positions
7sold out
1famous investor
$2.42avg. 13F price*
At the end of Q2 2025, 32 institutions reported holding Novabridge Biosciences (NBP) in their 13F filings, up 3 from Q1 2025. 10 opened new positions and 7 sold out. The largest holders were HHLR Advisors, LTD. ($14.5M), Candriam S.C.A. ($2.7M) and SG Americas Securities, LLC ($2.1M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Novabridge Biosciences
- Filed as
- I MAB (Q2 2025)
- CUSIP
- 44975P103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $3.3M |
| Exits | 7 | $546K |
All 13F filers, Q1 2025 → Q2 2025: 1,477,785 shares bought and 1,074,806 shares sold, net +402,979 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| HHLR Advisors, LTD. | 0.47% | No change | 5,980,568 | $14.5M |
| Candriam S.C.A. | 0.02% | New | 1,132,563 | $2.7M |
| SG Americas Securities, LLC | 0.01% | Add +6.6% | 876,353 | $2.1M |
| Two Sigma Advisers, LP | 0.00% | Reduce -42.4% | 209,383 | $507K |
| UBS Group AG | 0.00% | Reduce -42.0% | 184,845 | $447K |
| Aberdeen Group plc | 0.00% | Reduce -16.1% | 136,471 | $330K |
| BNP Paribas Financial Markets | 0.00% | Add +1.2% | 122,405 | $296K |
| Two Sigma Investments, LP | 0.00% | Reduce -46.2% | 113,262 | $274K |
| Ariose Capital Management Ltd | 0.15% | New | 96,455 | $233K |
| Alberta Investment Management Corp | 0.00% | No change | 74,723 | $181K |
| Renaissance Technologies | 0.00% | Reduce -0.2% | 63,700 | $154K |
| Dimensional Fund Advisors LP | 0.00% | No change | 58,358 | $141K |
| Morgan Stanley | 0.00% | Add +67.4% | 58,295 | $141K |
| Geode Capital Management, LLC | 0.00% | Add +147.6% | 54,562 | $132K |
| Susquehanna International Group, LLP | 0.00% | New | 37,537 | $91K |
| CreativeOne Wealth, LLC | 0.00% | New | 37,430 | $91K |
| Barclays PLC | 0.00% | No change | 30,370 | $73K |
| Mariner, LLC | 0.00% | No change | 28,760 | $70K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | New | 27,800 | $67K |
| HRT Financial LP | 0.00% | Add +57.0% | 25,110 | $60K |
| Two Sigma Securities, LLC | 0.00% | New | 12,821 | $31K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -0.0% | 10,682 | $26K |
| Baxter Bros Inc. | 0.00% | New | 10,000 | $24K |
| Freestone Capital Holdings, LLC | 0.00% | No change | 10,000 | $24K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1,248 | $3K |
| Raymond James Financial Inc. | 0.00% | New | 1,000 | $2K |
| Bank of America Corp. | 0.00% | No change | 566 | $1K |
| Rhumbline Advisers | 0.00% | Reduce -7.8% | 333 | $805 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -66.3% | 305 | $738 |
| Citigroup Inc. | 0.00% | No change | 50 | $121 |
| Osaic Holdings, Inc. | 0.00% | No change | 30 | $72 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is NBP's weight in each manager's 13F, not the share of Novabridge Biosciences the manager owns.